Author:
Alotaibi Manal,Trollinger Brandon,Kant Sam
Abstract
AbstractPatients with kidney transplants have a significant co-morbidity index, due to a high number of pre-existing conditions and use of immunosuppression medications. These patients are at higher risk of developing conditions such as hypertension, dyslipidemia, post-transplant diabetes, cardiovascular events, and anemia. Moreover, they are particularly susceptible to infections such as urinary tract infections or pyelonephritis, cancers, and gastrointestinal complications such as diarrhea, which in turn may be attributed to medication adverse effects or infectious causes. Along with these concerns, meticulous management of electrolytes and allograft function is essential. Prior to prescribing any new medications, it is imperative to exercise caution in identifying potential interactions with immunosuppression drugs. This review aims to equip primary care practitioners to address these complex issues and appropriate methods of delivering care to this rapidly growing highly susceptible group.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Fritz K, et al. United Network for Organ Sharing (UNOS) database analysis of factors Associated with kidney transplant time on Waiting List. Cureus. 2023;15(2):e34679.
2. Lentine KL, et al. OPTN/SRTR 2021 Annual Data Report: kidney. Am J Transpl. 2023;23(2 Suppl 1):S21–S120.
3. Wu C, et al. Comorbid conditions in kidney transplantation: association with graft and patient survival. J Am Soc Nephrol. 2005;16(11):3437–44.
4. Gabardi S, et al. Induction immunosuppressive therapies in renal transplantation. Am J Health Syst Pharm. 2011;68(3):211–8.
5. Department of Health and Human Services, Health Resources and Services Administration: Organ procurement and transplantation network (OPTN) and scientific registry of transplant recipients (SRTR). OPTN/SRTR 2021 annual data report (2023) 2023.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献